Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
- PMID: 21743467
- PMCID: PMC3396006
- DOI: 10.1038/ng.882
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Abstract
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10(-8) to P = 2.7 × 10(-24)). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining ∼25% of the familial risk in this disease, have now been identified.
Figures



Similar articles
-
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.Nat Genet. 2009 Oct;41(10):1116-21. doi: 10.1038/ng.450. Epub 2009 Sep 20. Nat Genet. 2009. PMID: 19767753 Free PMC article.
-
Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.BJU Int. 2013 Jun;111(7):1148-55. doi: 10.1111/j.1464-410X.2012.11492.x. Epub 2012 Sep 18. BJU Int. 2013. PMID: 22985493 Free PMC article.
-
Genome-wide association study identifies new prostate cancer susceptibility loci.Hum Mol Genet. 2011 Oct 1;20(19):3867-75. doi: 10.1093/hmg/ddr295. Epub 2011 Jul 8. Hum Mol Genet. 2011. PMID: 21743057 Free PMC article.
-
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Hum Mol Genet. 2013 Jan 15;22(2):408-15. doi: 10.1093/hmg/dds425. Epub 2012 Oct 12. Hum Mol Genet. 2013. PMID: 23065704 Free PMC article.
-
Genetic predisposition to prostate cancer.Br Med Bull. 2016 Dec;120(1):75-89. doi: 10.1093/bmb/ldw039. Epub 2016 Oct 6. Br Med Bull. 2016. PMID: 27941040 Review.
Cited by
-
Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture.Cancer Discov. 2022 Dec 2;12(12):2838-2855. doi: 10.1158/2159-8290.CD-22-0027. Cancer Discov. 2022. PMID: 36108240 Free PMC article.
-
One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study.Prostate. 2013 May;73(7):677-89. doi: 10.1002/pros.22608. Epub 2012 Dec 19. Prostate. 2013. PMID: 23255287 Free PMC article.
-
DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications.Front Oncol. 2019 Jun 11;9:489. doi: 10.3389/fonc.2019.00489. eCollection 2019. Front Oncol. 2019. PMID: 31245293 Free PMC article. Review.
-
Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells.Oncotarget. 2019 Mar 19;10(23):2292-2305. doi: 10.18632/oncotarget.26765. eCollection 2019 Mar 19. Oncotarget. 2019. PMID: 31040920 Free PMC article.
-
Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management.J Clin Med. 2021 Aug 23;10(16):3760. doi: 10.3390/jcm10163760. J Clin Med. 2021. PMID: 34442055 Free PMC article. Review.
References
-
- Eeles RA, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–321. - PubMed
-
- Al Olama AA, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009;41:1058–1060. - PubMed
-
- Varghese JS, Easton DF. Genome-wide association studies in common cancers--what have we learnt? Curr Opin Genet Dev. 2010;20:201–209. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 10588/CRUK_/Cancer Research UK/United Kingdom
- G0900871/MRC_/Medical Research Council/United Kingdom
- 11022/CRUK_/Cancer Research UK/United Kingdom
- R01 CA072818/CA/NCI NIH HHS/United States
- R01 CA082664/CA/NCI NIH HHS/United States
- R01 CA128813/CA/NCI NIH HHS/United States
- 10119/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
- T32 GM007814/GM/NIGMS NIH HHS/United States
- R01 CA084979/CA/NCI NIH HHS/United States
- A10119/CRUK_/Cancer Research UK/United Kingdom
- R01 CA056678/CA/NCI NIH HHS/United States
- R01 CA092579/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- A10124/CRUK_/Cancer Research UK/United Kingdom
- P30 CA042014/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical